Team

Our leadership consists of a passionate management team with diverse industry knowledge, committed to science, therapeutic drug discovery and development.

With a highly-accomplished Board of Directors and BioSciences team, we have the adequate depth and breadth required to pursue our strategic vision.

Management Team

Raza Bokhari, MD

Executive Chairman of the Board and CEO

Dr. Raza Bokhari joined the board of FSD Pharma in August 2018 and was named Executive Co-Chairman of the Board in December, Interim CEO in February 2019 and Permanent CEO in June 2019. Dr. Bokhari has been responsible for developing and leading FSD’s strategic vision into synthetic cannabinoid platforms.

Learn More »

Nathan Coyle, CPA

Chief Financial Officer

Nathan Coyle joined FSD Pharma Inc in 2020 as Corporate Controller and was appointed to the Interim Chief Financial Officer role in 2021. Mr. Coyle has 15 years of executive business experience as a finance leader in both public and private roles. With a keen eye for analytical analysis and innovative ideas he has always led his team to success.

Learn More »

Maryann Adesso

Chief of Staff

Maryann Adesso serves as the Chief of Staff for Dr. Raza Bokhari, Executive Co-Chair of FSD Pharma, Inc. In this role she coordinates and streamlines various business, academic and not for profit global engagements of Dr. Bokhari, a serial entrepreneur and philanthropist based in the Keystone region.

Learn More »

Edward Brennan, Jr., MD, FACS

Chief Medical Officer

Dr. Edward J. Brennan, Jr., has more than 25 years of experience in leadership roles at major pharmaceutical companies and clinical research organizations. He is an accomplished biopharmaceutical executive with a proven track record in FDA submissions and drug development.

Learn More »

Huma Qamar, MD, MPH

Senior Vice President, Head of R&D Program

Dr. Qamar has worked in the clinical research field for some of the most renowned Ivy League institutions such as Yale, Harvard and University of Pennsylvania. She has served in key roles in major hospitals such as Thomas Jefferson University Hospital, The Children's Hospital of Philadelphia, Hospital of the University of Pennsylvania, and Fox Chase Cancer Center.

Learn More »

Sara May, PhD

Senior Vice-President

Dr. Sara May is a Ph.D. graduate with a multidisciplinary background in plant breeding and crop genetics with over ten years’ experience designing, implementing and managing large-scale projects in the field, lab and greenhouse. She is the former President of FV Pharma, Inc., and has extensive work experience with all aspects of National, International, Provincial and Regional Legislative Acts and Regulations. Dr. May has deep domain expertise in the Medical Cannabis industry, which includes managing large scale operations, developing and implementing quality control and quality assurance methods and standard operating procedures and HACCP.

Learn More »

Board of Directors

Raza Bokhari, MD

Executive Chairman of the Board and CEO

Dr. Raza Bokhari joined the board of FSD Pharma in August 2018 and was named Executive Co-Chairman of the Board in December, Interim CEO in February 2019 and Permanent CEO in June 2019. Dr. Bokhari has been responsible for developing and leading FSD’s strategic vision into synthetic cannabinoid platforms.

Learn More »

Anthony Durkacz

Director and Founder

Anthony Durkacz is currently a Director and Executive Vice President at First Republic Capital Corporation, which he joined in January 2014. First Republic has acted as the exclusive agent of the company and has raised approximately $53 million of equity capital to date.

Learn More »

The Honorable Stephen Buyer

Director

Stephen Buyer was a member of the United States House of Representatives, serving nine consecutive terms from January 1993 to January 2011. During Congressman Buyer’s long tenure in the Congress, he served on the Committees on Veterans Affairs, Armed Services, Judiciary, Energy and Commerce Committees and also served on the Military Compensation and Retirement Modernization Commission. He is presently the Managing Partner of the 10-Square Solution, LLC, focusing on business development, mergers and acquisitions, and representation before the federal government.

Learn More »

Robert J. Ciaruffoli, CPA

Director

Robert J. Ciaruffoli is a co-founder and vice-chairman of Broad Street Angels, a 100 member Philadelphia based angel investor network which invests in start-up entrepreneurial businesses with high growth potential. Broad Street Angels is the largest angel investor network in the Philadelphia region. 

Learn More »

Gerald Goldberg, CPA, CA

Director

Gerald Goldberg, CPA, CA, has over 30 years of experience in the service, distribution, retail, mining, natural resources and oil & gas, real estate, not-for-profit entities and manufacturing industries, with a strong emphasis in taxation and business advisory services.

Learn More »

Larry Kaiser, MD, FACS

Director

Dr. Kaiser is currently the Managing Director with the Healthcare Industry Group at Alvarez and Marsal, a leading global professional services firm. Most recently, Dr. Kaiser was the President and CEO of the $2.2 billion Temple University Health System, Dean of Temple University’s Lewis Katz School of Medicine, and Senior Executive Vice President for Health Sciences at Temple University.

Learn More »